Literature DB >> 11704429

Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements.

N Sabir1, Y Sermez, S Kazil, M Zencir.   

Abstract

PURPOSE: This study has two objectives: (1) using ultrasound (US) as a tool for measuring subcutaneous (S) and intra-abdominal; preperitoneal (P) and visceral (V) fat thickness. (2) Assessing the relationship between selected anthropometrical variables and US-measured S, P and V fat also evaluating the contribution of abdominal fat accumulation in development of liver steatosis. METHODS AND MATERIALS: Sixty-eight obese patients (aged 43.9+/-9.3 years) and 40 non-obese subjects (aged 34.03+/-9.0 years) were recruited to this study. Height, weight (W), waist (WC) and hip circumferences were measured. Body mass index (BMI) and waist to hip ratio (WHR) were calculated. A linear-array probe (7.5 MHz) was used to measure S and P. A convex-array probe (3.5 MHz) was used for measuring V and assessing liver fatty infiltration.
RESULTS: In 45 (66%) patients, there were diffuse liver fatty changes. Liver steatosis showed significant correlation with V (r=0.57), P (r=0.38) and S (r=0.37). It also correlated with W (r=0.52), BMI (r=0.6), WC (r=0.45) (P<0.0001). V positively correlated with BMI (r=0.62), W (r=0.55), WC (r=0.52) and WHR (r=0.33). P correlated with WC (r=0.29), WHR (r=0.36) and W (r=0.34), but not with BMI, height and age. A significant correlation was found between S and BMI (r=0.73), W (r=0.65), and WC (r=0.57) (P<0.0001).
CONCLUSION: Obese patients showed thicker S, P, and V. Liver steatosis correlates significantly with both anthropometrical data; BMI, WHR, WC, and W, and with abdominal V, P, and S fat. V fat can be used as a good predictor for the possibility of different metabolic disorders and liver disturbances as steastosis.

Entities:  

Mesh:

Year:  2001        PMID: 11704429     DOI: 10.1016/s0929-8266(01)00153-7

Source DB:  PubMed          Journal:  Eur J Ultrasound        ISSN: 0929-8266


  25 in total

1.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

Authors:  Lei Shen; Jian-Gao Fan; Yan Shao; Min-De Zeng; Jun-Rong Wang; Guo-Hao Luo; Ji-Qiang Li; Si-Yao Chen
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

2.  The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy.

Authors:  Raquel M S Campos; Aline de Piano; Patrícia L da Silva; June Carnier; Priscila L Sanches; Flávia C Corgosinho; Deborah C L Masquio; Marise Lazaretti-Castro; Lila M Oyama; Cláudia M O Nascimento; Lian Tock; Marco Túlio de Mello; Sergio Tufik; Ana R Dâmaso
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

Review 3.  Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment.

Authors:  Benjamin W Redan; Kimberly K Buhman; Janet A Novotny; Mario G Ferruzzi
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

4.  Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.

Authors:  Elisabeth Wehr; Reinhard Möller; Renate Horejsi; Albrecht Giuliani; Daisy Kopera; Natascha Schweighofer; Andrea Groselj-Strele; Thomas R Pieber; Barbara Obermayer-Pietsch
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  Doppler waveform of the hepatic veins in an obese population.

Authors:  Nevzat Karabulut; Selçuk Kazil; Baki Yagci; Nuran Sabir
Journal:  Eur Radiol       Date:  2004-07-22       Impact factor: 5.315

6.  Ultrasound, anthropometry and bioimpedance: a comparison in predicting fat deposition in non-alcoholic fatty liver disease.

Authors:  Nicola Vitturi; Marta Soattin; Fabio De Stefano; Daniela Vianello; Alberto Zambon; Mario Plebani; Luca Busetto
Journal:  Eat Weight Disord       Date:  2014-08-17       Impact factor: 4.652

7.  Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.

Authors:  Nicola Imperatore; Raffaella Tortora; Anna Testa; Nicolò Gerbino; Nicola Caporaso; Antonio Rispo
Journal:  J Gastroenterol       Date:  2017-08-19       Impact factor: 7.527

8.  Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats.

Authors:  Ying Qin; Ya-ping Tian
Journal:  Lipids Health Dis       Date:  2010-07-26       Impact factor: 3.876

9.  Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice.

Authors:  Ying Qin; Ya-ping Tian
Journal:  J Transl Med       Date:  2010-11-19       Impact factor: 5.531

10.  Cholecystosteatosis: an explanation for increased cholecystectomy rates.

Authors:  Hayder H Al-Azzawi; Attila Nakeeb; Romil Saxena; Mary A Maluccio; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.